Assessment of IL-10 Polymorphism and TGF beta 1 Polymorphism in Egyptian Patients with Chronic Liver Disease | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 13, Volume 72, Issue 8, July 2018, Page 5026-5033 PDF (482.23 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2018.10282 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Magda H. Osman1; Radwa S. Shahin1; Wafaa M. Elzefzafy2; Maha R. Ghazzawi  1
| ||||
| 1Department of Clinical and Chemical Pathology, Faculty of Medicine (for Girls), Al-Azhar University | ||||
| 2Department of Tropical Medicine, Faculty of Medicine (for Girls), Al-Azhar University | ||||
| Abstract | ||||
| Aim of the work: to determine the role of Interleukin-10 (IL-10) polymorphism (rs 1800896) and Transforming Growth Factor-Beta-1(TGF-β1) polymorphism (509 CT) as markers for cirrhosis in Egyptian patients with chronic liver disease. Subjects and Methods: This case-control study was carried out on selected patients admitted to Tropical medicine department, Al Zahraa University Hospital during the period from March 2016 to April 2017. Genotyping of IL-10 (rs 1800896) and TGF-β1 (509 CT) polymorphisms were performed using real-time polymerase chain reaction (PCR) technique. Results: There was significant increase in IL10 and TGF β1 509 gene polymorphisms in compensated and de-compensated groups as compared to control group. Conclusion: Interleukin 10 rs 1800896 gene polymorphism and TGF β1 509 gene polymorphism are associated with risk of liver cirrhosis in patients with chronic hepatitis C virus infection. These findings could be useful for future screening for early detection of liver cirrhosis. | ||||
| Keywords | ||||
| IL-10; Polymorphism; TGF Beta; Chronic liver disease | ||||
|
Statistics Article View: 157 PDF Download: 340 |
||||
